Connect with us

Foreign news

China approves emergency usage of COVID-19 vaccines, official says

Published

on

A Chinese health official Saturday confirmed the country authorized emergency usage of COVID-19 vaccines developed by some select domestic companies on July 22.

“We’ve drawn up a series of plan packages, including medical consent forms, side-effects monitoring plans, rescuing plans, compensation plans, to make sure the emergency use is well regulated and monitored,” Zheng Zhongwei, head of China’s coronavirus vaccine development task force told CCTV.

An emergency use authorization, which is based on Chinese vaccine management law, allows unapproved vaccine candidates to be used among people who are at high risk of getting infected on a limited period.

By first inoculating the special groups, like frontline medical workers and civil servants, the move is to ensure that a city can keep normal functions when a health crisis strikes, the law stated.

Similar authorizations have been legalized in many countries. For example, U.S. Food and Drug Administration allows unapproved medical products to be used in an emergency to diagnose, treat or prevent life-threatening disease or conditions.

The national agency has used several emergency use authorizations since the coronavirus outbreak as a way to get many diagnostic tests more quickly to the market than the normal procedures.

“We are planning to scale up the inoculating group to better prepare for a possible next wave in autumn and winter,” Zheng added.

A new coronavirus vaccine cultivated within insect cells by West China Hospital of Sichuan University in Chengdu has been approved for human trial, according to local government on Saturday.

Using insect cells to grow proteins for the coronavirus vaccine – a first in China – could speed up large-scale production, the Chengdu city government said in a notice on its official WeChat account.

Animal tests have shown promising results in preventing coronavirus infection, the notice said, and no obvious side effects have found.

According to China’s National Medical Products Administration, at least eight potential coronavirus vaccines have entered different stages of clinical trials.

In an interview with CCTV, Yang Xiaoming, chief scientist of China’s vaccine development and CEO of China National Biotec Group (CNBG) said they’ve signed agreements with many countries on inactivated vaccine clinical trials over the past few months.

“Over 20,000 people has been vaccinated,” Yang added, “Vaccine safety is well guaranteed; the effectiveness is being closely monitored.”

The company announced on late Friday Argentina joined Peru, Morocco and the United Arab Emirates (UAE) in approving Phase 3 clinical trials for their inactivated coronavirus vaccine.

The experimental vaccine by CNBG received approval from the UAE in June for a Phase 3 trial and has since recruited 15,000 volunteers, according to the company.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

Featured

Financing Health Futures: Nigeria, Ghana, Uganda Turn to Tobacco and Telecom Taxes in Big Push Against Malaria

Published

on

African leaders, parliamentarians, health experts, and development partners have renewed their commitment to ending malaria by 2030, with a bold call for domestic financing through innovative taxation on tobacco, alcohol, and telecom services to close critical funding gaps.

The discussions took center stage at the Big Push Against Malaria: Harnessing Africa’s Role high-level political engagement in Abuja, where Nigeria, Ghana, and Uganda showcased new homegrown financing strategies aimed at reducing dependence on dwindling donor support.

Africa’s Heavy Burden

Malaria remains one of Africa’s deadliest diseases. In 2023, the world recorded 263 million cases and nearly 600,000 deaths, with 94% of cases and 95% of deaths occurring in Africa. Nigeria alone accounted for 26.6% of global cases and 31% of deaths, according to the World Malaria Report 2024. Children under five remain the most vulnerable, making up 76% of deaths.

Despite progress — with Nigeria cutting malaria deaths by more than half since 2000 through insecticide-treated nets, preventive treatments, and the rollout of the new R21 malaria vaccine — leaders warned that global targets are off-track. The World Health Organization’s technical strategy for malaria (2016–2030) has stalled since 2017, with Africa unlikely to meet its 2025 and 2030 milestones without urgent action.

Taxing for Health Futures

The Nigerian Parliament’s Committee on HIV/AIDS, Tuberculosis, and Malaria (ATM) announced plans to fund malaria elimination through “sin taxes” and telecom levies.

According to the House Chair on ATM, Hon. Linda Ogar, a bill is underway to restructure the National Agency for the Control of AIDS (NACA) into a multi-disease agency that will address HIV, TB, and malaria.

The new financing mechanism proposes:

Taxes on tobacco, alcohol, and other luxury items

Dedicated levies on telecom airtime and mobile money transactions

A percentage of the nation’s consolidated revenue

“These resources will provide sustainable funding to strengthen health systems and accelerate malaria elimination,” Ogar said, stressing that Africa must stop relying solely on foreign donors. “We cannot continue to take two steps forward and five steps backward. Africa must begin to show the world that we are ready to solve our problems ourselves.”

Similar models are already being piloted in Ghana and Uganda, where levies on mobile money and telecoms are being redirected to finance health interventions. The Abuja meeting urged other African countries to adopt this approach as part of a continental framework for sustainable financing.

Leaders Call for Urgent Action

Nigeria’s Minister of State for Health and Social Welfare, Dr. Iziaq Adekunle Salako, emphasized that while malaria is preventable and treatable, it still kills hundreds of thousands yearly due to funding shortfalls, climate change, insecticide resistance, and humanitarian crises.

“To truly defeat this disease, we must rethink, join forces, and mount a concerted ‘Big Push’. Funding gaps remain a major obstacle, and innovative domestic financing is the way forward,” Salako declared.

From the civil society front, grassroots representatives pledged to act as “foot soldiers”, demanding that communities have a seat at the decision-making table. The World Health Organization, Bill & Melinda Gates Foundation, Aliko Dangote Foundation, and other partners reaffirmed support but stressed the need for stronger political will and local ownership.

Private Sector and Global Support

Representing billionaire philanthropist Aliko Dangote, the Nigeria Malaria Council reiterated that private sector investment must complement government financing. Meanwhile, the Global Fund confirmed it has invested nearly $2 billion in Nigeria’s malaria response and committed an additional $500 million for 2024–2026, including support for local production of malaria drugs.

The Gates Foundation’s Uche Anaowu noted that while progress has slowed, malaria remains beatable:

“Smallpox is the only human disease ever eradicated. The question is — can malaria be next? I believe Africa has both the burden and the opportunity to lead the world in making that happen.”

Financing Health Futures: Nigeria, Ghana, Uganda Turn to Tobacco and Telecom Taxes in Big Push Against Malaria

Abuja, Nigeria – African leaders, parliamentarians, health experts, and development partners have renewed their commitment to ending malaria by 2030, with a bold call for domestic financing through innovative taxation on tobacco, alcohol, and telecom services to close critical funding gaps.

The discussions took center stage at the Big Push Against Malaria: Harnessing Africa’s Role high-level political engagement in Abuja, where Nigeria, Ghana, and Uganda showcased new homegrown financing strategies aimed at reducing dependence on dwindling donor support.

Africa’s Heavy Burden

Malaria remains one of Africa’s deadliest diseases. In 2023, the world recorded 263 million cases and nearly 600,000 deaths, with 94% of cases and 95% of deaths occurring in Africa. Nigeria alone accounted for 26.6% of global cases and 31% of deaths, according to the World Malaria Report 2024. Children under five remain the most vulnerable, making up 76% of deaths.

Despite progress — with Nigeria cutting malaria deaths by more than half since 2000 through insecticide-treated nets, preventive treatments, and the rollout of the new R21 malaria vaccine — leaders warned that global targets are off-track. The World Health Organization’s technical strategy for malaria (2016–2030) has stalled since 2017, with Africa unlikely to meet its 2025 and 2030 milestones without urgent action.

Taxing for Health Futures

The Nigerian Parliament’s Committee on HIV/AIDS, Tuberculosis, and Malaria (ATM) announced plans to fund malaria elimination through “sin taxes” and telecom levies.

According to the House Chair on ATM, Hon. Linda Ogar, a bill is underway to restructure the National Agency for the Control of AIDS (NACA) into a multi-disease agency that will address HIV, TB, and malaria.

The new financing mechanism proposes:

Taxes on tobacco, alcohol, and other luxury items

Dedicated levies on telecom airtime and mobile money transactions

A percentage of the nation’s consolidated revenue

“These resources will provide sustainable funding to strengthen health systems and accelerate malaria elimination,” Ogar said, stressing that Africa must stop relying solely on foreign donors. “We cannot continue to take two steps forward and five steps backward. Africa must begin to show the world that we are ready to solve our problems ourselves.”

Similar models are already being piloted in Ghana and Uganda, where levies on mobile money and telecoms are being redirected to finance health interventions. The Abuja meeting urged other African countries to adopt this approach as part of a continental framework for sustainable financing.

Leaders Call for Urgent Action

Nigeria’s Minister of State for Health and Social Welfare, Dr. Iziaq Adekunle Salako, emphasized that while malaria is preventable and treatable, it still kills hundreds of thousands yearly due to funding shortfalls, climate change, insecticide resistance, and humanitarian crises.

“To truly defeat this disease, we must rethink, join forces, and mount a concerted ‘Big Push’. Funding gaps remain a major obstacle, and innovative domestic financing is the way forward,” Salako declared.

From the civil society front, grassroots representatives pledged to act as “foot soldiers”, demanding that communities have a seat at the decision-making table. The World Health Organization, Bill & Melinda Gates Foundation, Aliko Dangote Foundation, and other partners reaffirmed support but stressed the need for stronger political will and local ownership.

Private Sector and Global Support

Representing billionaire philanthropist Aliko Dangote, the Nigeria Malaria Council reiterated that private sector investment must complement government financing. Meanwhile, the Global Fund confirmed it has invested nearly $2 billion in Nigeria’s malaria response and committed an additional $500 million for 2024–2026, including support for local production of malaria drugs.

The Gates Foundation’s Uche Anaowu noted that while progress has slowed, malaria remains beatable:

“Smallpox is the only human disease ever eradicated. The question is — can malaria be next? I believe Africa has both the burden and the opportunity to lead the world in making that happen.”

The Big Push: From Talk to Action

Speakers acknowledged that Africa has hosted too many malaria meetings without concrete outcomes. This time, however, leaders insisted the Abuja gathering must mark a turning point — from dependency to self-reliance.

With Nigeria, Ghana, and Uganda setting the pace on tax-based health financing, the continent now faces the challenge of replicating and scaling up these models.

“Now that Africa is at a critical point, the need for a Big Push against malaria cannot be overemphasized. If we align political will, innovative financing, and community engagement, we can end malaria within our lifetime.”

Nigeria, Ghana, and Uganda are pioneering a shift from donor dependence to domestic revenue mobilization via tobacco, alcohol, and telecom taxes — a model hailed as central to financing Africa’s health futures and ending malaria by 2030
Speakers acknowledged that Africa has hosted too many malaria meetings without concrete outcomes. This time, however, leaders insisted the Abuja gathering must mark a turning point — from dependency to self-reliance.

With Nigeria, Ghana, and Uganda setting the pace on tax-based health financing, the continent now faces the challenge of replicating and scaling up these models.

“Now that Africa is at a critical point, the need for a Big Push against malaria cannot be overemphasized. If we align political will, innovative financing, and community engagement, we can end malaria within our lifetime.”

Nigeria, Ghana, and Uganda are pioneering a shift from donor dependence to domestic revenue mobilization via tobacco, alcohol, and telecom taxes — a model hailed as central to financing Africa’s health futures and ending malaria by 2030

Continue Reading

Trending

error

Enjoy this blog? Please spread the word :)